Showing results (11-20 of 343) with videos related to
Sort By:
Pageof 35
Cancer Journal (Sudbury, Mass.)|March 6, 2004
A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitorYumiko Hirokawa, Anjali Tikoo, John Huynh, et al.Journal of Visualized Experiments : Jove|March 26, 2013
An in vivo assay to test blood vessel permeabilityMaria Radu, Jonathan ChernoffCell Chemical Biology|July 21, 2023
TRIMming away colon cancer: TRIM21-mediated ubiquitination as an activator of the Hippo tumor suppressor pathwayDorothy Benton, Jonathan ChernoffThe Journal of Biological Chemistry|August 7, 2003
Protein-tyrosine phosphatase 1B mediates the effects of insulin on the actin cytoskeleton in immortalized fibroblastsShrikrishna Dadke, Jonathan ChernoffCancer Discovery|February 7, 2020
A New Rho(d) Map to Diffuse Gastric CancerDorothy Benton, Jonathan ChernoffCurrent Drug Targets. Immune, Endocrine and Metabolic Disorders|December 20, 2003
Protein-tyrosine phosphatase 1B as a potential drug target for obesityShrikrishna Dadke, Jonathan ChernoffGenome Biology|February 28, 2002
The evolutionary history of effectors downstream of Cdc42 and RacSophie Cotteret, Jonathan ChernoffMethods (San Diego, Calif.)|November 18, 2005
Production and use of a cell permeable inhibitor of group A Paks (TAT-PID) to analyze signal transductionAlexander Beeser, Jonathan ChernoffPageof 35